The Joan Rotondi Hope & Empowerment Foundation was created out of love, compassion, and humility. As a close-knit family of three, we always put each other first, guided by kindness and forgiveness. Joan, a beloved wife and devoted mother, saw each day as an opportunity for joy and embraced life with an open heart. Losing her to ovarian cancer made us realize how many women face similar challenges without early detection or proper resources. This foundation honors Joan by raising awareness, offering support, and empowering others to find hope in their darkest moments.

OUR MISSION
The Joan Rotondi Hope & Empowerment Foundation is a non profit organization supporting individuals battling ovarian cancer through initiatives focused on early detection, awareness campaigns, essential resources like financial aid for second opinions and AI-guided clinical trial navigation.
The facts behind the fight

Many studies indicate that ovarian cancer patients often feel unheard when discussing symptoms with their doctors¹

There is no universal screening program for ovarian cancer¹
50% of ultrasounds on adnexal masses return indeterminate results —not clearly benign or malignant²
60-70%
Most ovarian cancer diagnoses are caught at stage three or four³

Ovarian cancer diagnoses have a 33% survivability rate¹

EMPOWERING YOUR HEALTHCARE JOURNEY










¹ World Ovarian Cancer Coalition. (2023). World Ovarian Cancer Coalition Atlas 2023. Retrieved from https://worldovariancancercoalition.org/wp-content/uploads/2023/04/World-Ovarian-Cancer-Coalition-Atlas-2023-FINAL.pdf. Accessed 24 Aug. 2024.
² "Diagnostic Ultrasound in the Assessment of the Adnexal Mass." GLOWM, The Global Library of Women's Medicine, www.glowm.com/section-view/heading/diagnostic-ultrasound-in-the-assessment-of-the-adnexal-mass/item/15. Accessed 24 Aug. 2024.
³ American Cancer Society. "Detection, Diagnosis, and Staging of Ovarian Cancer." American Cancer Society, https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging.html. Accessed 24 Aug. 2024.